Published in
Lippincott, Williams & Wilkins, Current Opinion in Urology, 3(31), p. 236-241, 2021
DOI: 10.1097/mou.0000000000000870
Links
Tools
Individualizing renal cell carcinoma treatment through biomarkers discovery in the era of immune checkpoint inhibitors: where do we stand?
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 